About
Dr Pejman Bakhtiary is an ophthalmologist and cornea specialist certified by the American Board of Ophthalmology. He specializes in advanced corneal transplantation techniques, modern cataract surgery, ocular surface diseases, and comprehensive eye care. Dr. Pejman welcomes all patients, from those needing routine eye care to others who may be dealing with the most complex eye care issues.
He has completed an ophthalmology residency at Loma Linda University. He completed his fellowship training in Cornea, External Diseases and Refractive Surgery the prestigious Jules Stein Eye Institute at UCLA. Dr. Bakhtiary has a background in academic ophthalmology, has been an active participant in industry research initiatives, and he has authored dozens of peer-reviewed articles and made presentations in national and international ophthalmology meetings.
Education and Training
- Medical School
Doctor of Medicine, Shahid Beheshti University School Of Medicine, Tehran, Iran, (1998)
- Internship
General Surgery, University of Southern California, Los Angeles, California (2013 – 2014)
- Residency
Ophthalmology Residency, Loma Linda University, Loma Linda, California
(2014 – 2017)
- Fellowship
Cornea, External Disease and Refractive Surgery, UCLA Jules Stein Eye Institute, Los Angeles, California (2017 – 2018)
Professional Affiliations
- Board Certified – American Academy of Ophthalmology
- American Cornea Society (2017-Present)
- American Society of Cataract & Refractive Surgery (ASCRS) (2012-Present)
- American Academy of Ophthalmology( 2009-Present)
- Scientific Committee, Iranian Society of Ophthalmology (2007-2009)
Annual Meeting
- European Society of Cataract & Refractive Surgery (ESCRS) (2006-Present)
- Iranian Society of Ophthalmology (2003-3009)
Publications
- Medically reversible limbal stem cell disease: clinical features and management strategies.Kim BY, Riaz KM, Bakhtiari P, Chan CC, Welder JD, Holland EJ, Basti S, Djalilian AR. Ophthalmology. 2014 Oct;121(10):2053-8.
- Corneal keloid: report of natural history and outcome of surgical management in two cases. Bakhtiari P, Agarwal DR, Fernandez AA, Milman T, Glasgow B, Starr CE, Aldave AJ. Cornea. 2013 Dec;32(12):1621-4.
- Presentation, diagnosis and management of limbal stem cell deficiency.Sejpal K, Bakhtiari P, Deng SX. Middle East Afr J Ophthalmol. 2013 Jan-Mar;20(1):5-10.
- Exclusion of pathogenic promoter region variants and identification of novel nonsense mutations in the zinc finger E-box binding homeobox 1 gene in posterior polymorphous corneal dystrophy. Bakhtiari P, Frausto RF, Roldan AN, Wang C, Yu F, Aldave AJ.Mol Vis. 2013; 19:575-80.
- The international use of the Boston type I keratoprosthesis. Kim MJ, Bakhtiari P, Aldave AJ. Int Ophthalmol Clin. 2013 Spring;53(2):79-89.
- Surgical and Visual Outcomes of the Type I Boston Keratoprosthesis for the Management of Aniridic Fibrosis Syndrome in Congenital Aniridia. Bakhtiari P, Chan C, Welder JD, de la Cruz J, Holland EJ, Djalilian AR.Am J Ophthalmol. 2012 May;153(5):967-971
- Limbitis secondary to autologous serum eye drops in a patient with atopic keratoconjunctivitis, Case Rep Ophthalmol Med. 2011;2011:576521.
- Midterm Outcomes of Autologous Cultivated Limbal Stem Cell Transplantation With or Without Penetrating Keratoplasty. Baradaran-Rafii A, Ebrahimi M, Kanavi MR, Taghi-Abadi E, Aghdami N, Eslani M, Bakhtiari P, Einollahi B, Baharvand H, Javadi MA.Cornea. 2010 May; 29(5):502-9.
- Update on Limbal Stem Cell Transplantation. Bakhtiari P, Djalilian A. Middle East African J of Ophthalmology, 2010, Jan-Mar 1 (17):9-14.
- Cryotherapy of sclerotomy sites for prevention of late post–vitrectomy diabetic hemorrhage: a randomized clinical trial. Entezari M, Ramezani A, Ahmadieh H, Bakhtiari P, Yaseri M, Soltani K. Graefes Arch Clin Exp Ophthalmol. 2010 Jan; 248(1):13-9.
- Perilimbal bevacizumab injection for interface neovascularization following deep anterior lamellar keratoplasty. Foroutan A, Fariba B, P. Bakhtiari, Mahmoud J, Khalil GF, Arash EA, Foroutan P. Cornea. 2010 Nov: 29(11):1268-1272.
- Fibrin glue–assisted suture less scleral fixation.Falavarjani KG, Modarres M, Foroutan A, Bakhtiari P. J Cataract Refract Surg. 2009 May; 35(5):795; author reply 795-6.
- Retinoblastoma in Iran: outcomes in terms of patients’ survival and globe survival.Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Br J Ophthalmol. 2009 Jan; 93(1):28-32.
- EMLA cream application without occlusive dressing before upper facial botulinum toxin injection: a randomized, double–blind, placebo–controlled trial. Kashkouli MB, Salimi S, Bakhtiari P, Parvaresh MM, Sanjari MS, Naseripour M. Ann Plast Surg. 2008 Apr; 60(4):353-6.
- Cataract surgery for congenital cataract: endothelial cell characteristics, corneal thickness, and impact on intraocular pressure. Nilforushan N, Falavarjani KG, Razeghinejad MR, Bakhtiari P. J AAPOS. 2007 Apr; 11(2):159-61.Pupil dilation with intracameral lidocaine during phacoemulsification.Nikeghbali A, Falavarjani KG, Kheirkhah A, Bakhtiari P, Kashkouli MB. J Cataract Refract Surg. 2007 Jan; 33(1):101-3.
Awards and Achievements
- Basic and Clinical Certificates of the International Council of Ophthalmology (ICO), 2003, with Merit Award: Top 0.5 percentile of all annual examinees in 65 countries.
- 1st top title Resident nationwide, Iran National Board of Ophthalmology, 2003.
- Commendation letter for educational endeavors for the 1st title in Basic Science Exam nationwide, from President of University, Shahid Beheshti University of Medical Sciences, Tehran, 1992.
- Ranked within top 3 Medical Student Nationwide in Evaluation of the Iranian Medical Academy, with Commendation letter from the President of Academy, Tehran,1991.
- ARVO Travel Grant Winner May 2012.
- ASCRS Research Grant, 2016.
- Honored as Elsa and Louis Kelton Fellow at the Jules Stein Eye Institute, UCLA, 2017-2018.
